Sheri McCoy, during her tenure running Johnson & Johnson?s pharmaceuticals group, was the highest-ranking woman in the industry. Now, she?s leaving to run a beauty business, Avon Products. McCoy?s losing the horse race to become J&J?s CEO in February disappointed women in and around the pharmaceutical industry, whose executive ranks are dominated by men. J&J?s choice, Alex Gorsky, is considered a more than worthy pick, but McCoy was also considered capable and would have been a role model for the many women making their way up Big Pharma ladders. ?Where we see women in CEO roles is not in the Rx business,? said DeeDee DeMan, founder and chief executive of search firm Bench International. DeMan hopes the state of affairs will change, and says McCoy might be the first woman to run a drug maker, after further validating her worth at Avon. Yet there are plenty of examples of high-ranking women in Big Pharma who have departed. At J&J, for instance, McCoy had followed Chris Poon as the company?s highest-ranking female after Poon retired and took a job in academia. All this said, J&J and its rivals have nurtured the talents of a number of women now climbing various company management ranks. At J&J, a spokesman pointed out, women lead its commercial pharmaceutical businesses in North America, Europe and Asia. ?Johnson & Johnson is committed to having a robust pipeline of diverse business leaders, and we are proud of our record of promoting and developing women leaders in our company.? Sheri McCoy made important contributions across Johnson & Johnson throughout her career, and we continue to cultivate other talented women in prominent leadership roles,? the J&J spokesman said.
breaking news whitney houston carmen whitney houston last performance cpac straw poll breaking dawn part 2 breaking dawn part 2 whitney cummings
No comments:
Post a Comment